CalliSpheres® drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in patients with refractory liver metastases: a propensity score-matched multi-center study
Open Access
- 19 August 2026
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatic metastases management: A comparative review of surgical resection, thermal ablation, and stereotactic body radiation therapyEuropean Journal of Cancer, 2025
- de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysisCancer Causes & Control, 2025
- Pickering emulsion with tumor vascular destruction and microenvironment modulation for transarterial embolization therapyBiomaterials, 2024
- Efficacy of CalliSpheres ® drug-loaded microspheres combined with doxorubicin in hepatocellular carcinomaScandinavian Journal of Gastroenterology, 2024
- Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysisJournal of Cancer Research and Clinical Oncology, 2024
- The second-line treatment of hepatocellular carcinoma with CalliSpheres drug-eluting bead transarterial chemoembolization combined with regorafenib: A safety and efficacy analysisIrish Journal of Medical Science (1971 -), 2024
- Explosomes: A new modality for DEB-TACE local delivery of sorafenib: In vivo proof of sustained releaseJournal of Controlled Release, 2023
- Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional ExperienceAcademic Radiology, 2023
- Variation of NK, NKT, CD4+ T, CD8+ T cells, and IL-17A by CalliSpheres® microspheres-transarterial chemoembolization in refractory liver metastases patientsScandinavian Journal of Clinical and Laboratory Investigation, 2022
- Epidemiology of liver metastasesCancer Epidemiology, 2020